Melanóma: vizsgálatok itt: Spanyolország
51 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 1. fázisTaking peoplePharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
- Where
- Barcelona, Madrid, Murcia, Sabadell, Sevilla
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Biocon Biologics UK PLC
See details and how to joinNCT07476326 · EU 2025-525158-20-00 - 1. fázisTaking peoplePhase 1 Study of PF-08046033 in Advanced Solid Tumors
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Pfizer
See details and how to joinNCT07519655 - 2. fázisTaking peopleA Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Barcelona, Hospitalet, Madrid, Seville
- Életkor
- 18 év and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680 - 4. fázisTaking peopleDabrafenib and/or Trametinib Rollover Study
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év to 100 év
- People
- 100 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT03340506 · EU 2023-509318-13-00 - 2. fázisTaking peopleDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- A Coruña, Barcelona, Girona, L'Hospitalet de Llobregat, Logrono
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - 3. fázisTaking peopleStudy to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
- Where
- Barcelona, Bilbao, Huelva, Lleida, Madrid, Málaga, Sabadell, Seville, Torrejón de Ardoz
- Életkor
- 18 év and over
- People
- 632 worldwide
- Run by
- mAbxience Research S.L.
See details and how to joinNCT07221734 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Madrid, Málaga, Seville, Valencia
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Sevilla
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - No phaseTaking peopleDevelopment and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Mitra Bio
See details and how to joinNCT07883954 - 1. fázisTaking peopleA PK study to compare JPB898 (proposed nivolumab biosimilar) and US-licensed Opdivo® in participants with resected stage IIB, IIC, or III melanoma in the adjuvant setting
- Where
- Badajoz, Barcelona, Cáceres, Granada, Jerez De La Frontera, Las Palmas de Gran Canaria, Lleida, Madrid, Majadahonda, Málaga, Oviedo, Pozuelo de Alarcón, Sabadell, San Cristóbal de La Laguna, Santander, Sevilla, Torrejón de Ardoz, Valencia
- Életkor
- 18 év and over
- People
- 83 worldwide
- Run by
- H e x a l AG
See details and how to join2025-521919-39-00 · EU 2025-521919-39-00 - 1/2. fázisTaking peopleA Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Where
- Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Valencia
- Életkor
- 18 év and over
- People
- 1438 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07070232 · EU 2024-517261-16-00 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Badalona, Barcelona, Cáceres, Girona, Jerez de la Frontera, Las Palmas de Gran Canaria, Lugo, Madrid, Málaga, Murcia, Santander, Santiago de Compostela, Valencia
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 2. fázisNot yet taking people in SpanyolországPHOENIX - ECP: Extracorporeal PHotopheresis for immune-related cOlitis and/or hEpatitis in advanced melaNoma with inadequate response to steroId eXposure
- Where
- Barcelona, Madrid, Murcia
- Életkor
- 18 év and over
- People
- 46 worldwide
- Run by
- Therakos Europe Limited
See details and how to join2026-526261-14-00 · EU 2026-526261-14-00 - 1. fázisTaking peopleA Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Logroño, Madrid
- Életkor
- 18 év and over
- People
- 124 worldwide
- Run by
- Pliant Therapeutics, Inc.
See details and how to joinNCT06270706 - 2. fázisTaking peopleA Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06961006 - 3. fázisTaking peopleStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Santander, Sevilla, Valencia
- Életkor
- 18 év to 70 év
- People
- 670 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00 - 1/2. fázisTaking peopleBI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- BioInvent International AB
See details and how to joinNCT04752826 · EU 2023-509847-29-00 - 2. fázisTaking peopleNeoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
- Where
- L'Hospitalet de Llobregat, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 19 worldwide
- Run by
- Grupo Español Multidisciplinar de Melanoma
See details and how to joinNCT07057596 · EU 2023-509076-42-00 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- A Coruña, Barcelona, Girona, Las Palmas de Gran Canaria, Madrid, Málaga, Sabadell, Santiago de Compostela, Valencia
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - 1. fázisTaking peopleA Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Where
- Barcelona, Las Palmas de Gran Canaria, Madrid, Málaga, Seville, Valencia
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT04913285 - 1. fázisTaking peoplePharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
- Where
- Badalona, Barcelona, Cáceres, L'Hospitalet de Llobregat, Madrid, Málaga, Pozuelo de Alarcón, Sevilla
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Alvotech Swiss AG
See details and how to joinNCT07475572 · EU 2025-525093-11-00 - 3. fázisCsak meghívásosA Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma
- Where
- L'hospitalet De Llobregat, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Aura Biosciences
See details and how to joinNCT07338968 · EU 2025-524405-33-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Badalona, Barcelona, Madrid, Málaga, Pamplona
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1/2. fázisTaking peopleA Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 366 worldwide
- Run by
- Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01 - 1. fázisTaking peopleSafety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
- Where
- Barcelona, Madrid, Valencia
- Életkor
- 18 év and over
- People
- 106 worldwide
- Run by
- MonTa Biosciences ApS
See details and how to joinNCT04855435 · EU 2024-512294-26-00